최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of magnetic resonance imaging : JMRI, v.33 no.4, 2011년, pp.889 - 897
Jeong, Woo Kyoung (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea) , Byun, Jae Ho (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea) , Lee, Seung Soo (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea) , Won, Hyung Jin (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea) , Kim, Kyoung Won (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea) , Shin, Yong Moon (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea) , Kim, Pyo Nyun (Department of Radiology and Research Ins) , Lee, Moon‐Gyu
AbstractPurpose:To compare the image quality and diagnostic performance of 1‐ and 3‐h delayed‐phase MR images (DPIs) after gadobenate dimeglumine injection in detecting small hepatocellular carcinomas (HCCs) in cirrhotic patients.Materials and Methods:Relative enhancement of the li...
1 Spinazzi A , Lorusso V , Pirovano G , Kirchin M . Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers . Acad Radiol 1999 ; 6 : 282 – 291 .
2 Kirchin M , Pirovano G , Spinazzi A . Gadobenate dimeglumine (Gd‐BOPTA): an overview . Invest Radiol 1998 ; 33 : 798 – 809 .
3 Manfredi R , Maresca G , Baron RL , et al. Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd‐BOPTA) . J Magn Reson Imaging 1999 ; 9 : 704 – 710 .
4 Kim YK , Lee JM , Kim CS . Gadobenate dimeglumine‐enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions . Eur Radiol 2004 ; 14 : 5 – 13 .
5 Del Frate C , Bazzocchi M , Mortele KJ , et al. Detection of liver metastases: comparison of gadobenate dimeglumine‐enhanced and ferumoxides‐enhanced MR imaging examinations . Radiology 2002 ; 225 : 766 – 772 .
6 Kim YK , Lee JM , Kim CS , Chung GH , Kim CY , Kim IH . Detection of liver metastases: gadobenate dimeglumine‐enhanced three‐dimensional dynamic phases and one‐hour delayed phase MR imaging versus superparamagnetic iron oxide‐enhanced MR imaging . Eur Radiol 2005 ; 15 : 220 – 228 .
7 Bruix J , Sherman M . Management of hepatocellular carcinoma . Hepatology 2005 ; 42 : 1208 – 1236 .
8 Marin D , Martino MD , Cuerrisi A , et al. Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine‐enhanced MR imaging and multiphasic 64‐section CT . Radiology 2009 ; 251 : 85 – 95 .
9 Cohen J . A coefficient of agreement for nominal scales . Educ Psychol Meas 1960 ; 20 : 37 – 46 .
10 Grazioli L , Morana G , Caudana R , et al. Hepatocellular carcinoma: correlation between gadobenate dimeglumine‐enhanced MRI and pathologic findings . Invest Radiol 2000 ; 35 : 25 – 34 .
11 Manfredi R , Maresca G , Baron RL , et al. Gadobenate dimeglumine (BOPTA) enhanced MR imaging: patterns of enhancement in normal liver and cirrhosis . J Magn Reson Imaging 1998 ; 8 : 862 – 867 .
12 Marti‐Bonmati L , Masia L , Casillas C , Ronchera‐Oms CL , Torrijo C . Differentiation of healthy from cirrhotic livers: evaluation of paramagnetic images after contrast administration in magnetic resonance imaging . Invest Radiol 1996 ; 31 : 768 – 773 .
13 Fujita T , Ito K , Honjo K , Okazaki H , Matsumoto T , Matsunaga N . Hepatic parenchymal enhancement in the cirrhotic liver: evaluation by triple‐phase dynamic MRI . Abdom Imaging 2002 ; 27 : 29 – 33 .
14 Planchamp C , Montet X , Frossard J‐L , et al. Magnetic resonance imaging with hepatospecific contrast agents in cirrhotic rat livers . Invest Radiol 2005 ; 40 : 187 – 194 .
15 Sidhu MK , Muller HH , Aggeler J , Jones AL , Young SW . Manganese dipyridoxal diphosphate‐enhanced magnetic resonance imaging in the evaluation of hepatocyte function . Invest Radiol 1993 ; 28 : 903 – 910 .
16 Marti‐Bonmati L , Lonjedo E , Poyatos C , Casillas C . MnDPDP enhancement characteristics and differentiation between cirrhotic and noncirrhotic livers . Invest Radiol 1998 ; 33 : 717 – 722 .
17 Murakami T , Baron RL , Federle MP , et al. Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn‐DPDP) . Radiology 1996 ; 198 : 567 – 572 .
18 Planchamp C , Gex‐Fabry M , Becker CD , Pastor CM . Model‐based analysis of Gd‐BOPTA‐induced MR signal intensity changes in cirrhotic rat livers . Invest Radiol 2007 ; 42 : 513 – 521 .
19 Ryeom HK , Kim SH , Kim JY , et al. Quantitative evaluation of liver function with MRI using Gd‐EOB‐DTPA . Korean J Radiol 2004 ; 5 : 231 – 239 .
20 de Haen C , Lorusso V , Luzzani F , Tirone P . Hepatic transport of the magnetic resonance imaging contrast agent gadobenate dimeglumine in the rat . Acad Radiol 1995 ; 2 : 232 – 238 .
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.